Conversely, in triple-negative breast cancer (TNBC) and HER2-positive cancers, where β-alanine levels are already elevated, additional supplementation might further activate metabolic pathways that support tumor survival and proliferation. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.